Tumor-derived mutated E-cadherin influences beta-catenin localization and increases susceptibility to actin cytoskeletal changes induced by pervanadate

Cell Adhes Commun. 2000 May;7(5):391-408. doi: 10.3109/15419060009109021.

Abstract

E-cadherin participates in homophilic cell-to-cell adhesion and is localized to intercellular junctions of the adherens type. In the present study, we investigated the localization of adherens junction components in cells expressing mutant E-cadherin derivatives which had been previously cloned from diffuse-type gastric carcinoma. The mutations are in frame deletions of exons 8 or 9 and a point mutation in exon 8 and affect the extracellular domain of E-cadherin. Our findings indicate that E-cadherin mutated in exon 8 causes beta-catenin staining at lateral cell-to-cell contact sites and, in addition, abnormally located beta-catenin in the perinuclear region. Moreover, the various mutant E-cadherin derivatives increased the steady-state levels of alpha- and beta-catenin and were found in association with these catenins even after induction of tyrosine phosphorylation by pervanadate. Sustained pervanadate treatment led, however, to rounding-up of cells and induction of filopodia, changes which were first detectable in cells expressing E-cadherin mutated in exon 8. The deterioration of the cell contact was not accompanied with disassembly of the E-cadherin-catenin complex. Based on these observations, we propose a model whereby in the presence of mutant E-cadherin tyrosine phoshorylation of components of the cell adhesion complex triggers loss of cell-to-cell contact and actin cytoskeletal changes which are not caused by the disruption of the E-cadherin-catenin complex per se, but instead might be due to phosphorylation of other signaling molecules or activation of proteins involved in the regulation of the actin cytoskeleton.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / metabolism
  • Actins / drug effects
  • Actins / metabolism
  • Animals
  • Cadherins / genetics
  • Cadherins / metabolism*
  • Catenins
  • Cell Adhesion Molecules / metabolism
  • Cell Line
  • Cytoskeletal Proteins / metabolism*
  • Cytoskeleton / drug effects*
  • Cytoskeleton / metabolism
  • Delta Catenin
  • Desmoplakins
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Mice
  • Mutation*
  • Phosphoproteins / metabolism
  • Phosphorylation
  • Protein Tyrosine Phosphatases / pharmacology*
  • Stomach Neoplasms / genetics
  • Trans-Activators*
  • Tumor Cells, Cultured
  • Tyrosine / metabolism
  • Vanadates / pharmacology*
  • alpha Catenin
  • beta Catenin

Substances

  • Actins
  • CTNNA1 protein, human
  • CTNNB1 protein, human
  • CTNNB1 protein, mouse
  • Cadherins
  • Catenins
  • Cell Adhesion Molecules
  • Ctnna1 protein, mouse
  • Cytoskeletal Proteins
  • Desmoplakins
  • Enzyme Inhibitors
  • Phosphoproteins
  • Trans-Activators
  • alpha Catenin
  • beta Catenin
  • pervanadate
  • Vanadates
  • Tyrosine
  • Protein Tyrosine Phosphatases
  • Delta Catenin